What is inContAlert?
inContAlert is pioneering advancements in medical technology with its proprietary wearable device designed for monitoring bladder fullness. Leveraging sophisticated sensor technology and machine learning algorithms, the system delivers timely alerts and recommendations to users via a dedicated app, offering a substantial improvement in the quality of life for individuals managing incontinence. The company's patented, non-invasive approach aims to optimize resource utilization in healthcare and nursing facilities by enabling efficient and personalized bladder control management, particularly for those with neurogenic bladders.
How much funding has inContAlert raised?
inContAlert has raised a total of $1.6M across 1 funding round:
Other Financing Round
$1.6M
Other Financing Round (2023): $1.6M with participation from CARMA FUND Management, High-Tech Gründerfonds, and Bayern Kapital
Key Investors in inContAlert
CARMA FUND Management
CARMA FUND is an early-stage investment fund based in Munich and Frankfurt am Main, focused on advancing Life Science and Healthcare technologies. With €56M under management, the fund supports young companies and projects in the medical space through flexible investment modes and strong industry partnerships.
High-Tech Gründerfonds
HTGF is a pre-seed and seed investor focusing on high-tech startups. The company supports tech founders who have the courage to shape the future, offering a strong network in both industry and academia, as well as deep tech expertise.
Bayern Kapital
Bayern Kapital is a leading venture capital investor in Bavaria, focusing on innovative, technology-oriented startups and companies across various sectors including High-Tech, DeepTech, and Life Sciences. They provide tailored financing solutions ranging from seed funds to growth funds.
What's next for inContAlert?
With this substantial backing, inContAlert is strategically positioned for its next phase of growth. The enterprise-level financing suggests a move towards scaling operations, expanding market reach, and potentially further refining its technology. Future developments may include broader clinical validation, strategic partnerships within the healthcare ecosystem, and the enhancement of its data analytics capabilities to provide deeper insights into patient care. This investment underscores the significant market potential and the critical need for advanced solutions in incontinence management.
See full inContAlert company page
